Evaxion to host r&d day on march 19, 2024, highlighting its latest technology innovations

Copenhagen, denmark, feb. 29, 2024 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, today announces that it will host a research & development (r&d) day focusing on its core ai-immunology™ platform on march 19, 2024, at 14:00 - 18:00 cet / 8:00 a.m. - 12:00 a.m. est.
EVAX Ratings Summary
EVAX Quant Ranking